Trials / Completed
CompletedNCT06183476
Circadian Amplification in Diabetic Retinopathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University of Illinois at Chicago · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from continuous glucose monitoring
Detailed description
This study will test the effects of a 6-week comprehensive circadian optimization intervention Amplify-RHYTHM in patients with diabetic retinopathy. The two main components of the intervention are timed light exposure and weekly remote coaching session by psychologist to optimize circadian and sleep behaviors. The outcomes of interest are objective and subjective sleep parameters, evening salivary cortisol and melatonin levels, and glucose parameters from continuous glucose monitoring
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Amplify-RHYTHM | Amplify-RHYTHM will have two main components: 1) timed light exposure (increase light in the morning, blue light reduction in the evening and eye masks at night), 2) weekly remote coaching session by psychologist to optimize circadian and sleep behaviors |
Timeline
- Start date
- 2024-03-20
- Primary completion
- 2025-01-10
- Completion
- 2025-01-10
- First posted
- 2023-12-27
- Last updated
- 2025-08-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06183476. Inclusion in this directory is not an endorsement.